Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection

被引：11
作者：
Anttila, VJ
Piilonen, A
Valtonen, M
机构：
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki 00029, Finland
[2] Univ Helsinki, Cent Hosp, Dept Radiol, Helsinki 00029, Finland
来源：
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2003年 / 35卷 / 11-12期
关键词：
D O I：
10.1080/00365540310016871
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A kidney transplant patient on cyclosporine treatment developed focal pneumonia due to Aspergillus fumigatus. The patient was not able to tolerate amphotericin B deoxycholate and was switched to caspofungin. The patient responded favourably without any evidence of toxicity from concomitant use of caspofungin and cylosporine.
引用
收藏
页码：893 / 894
页数：3
相关论文
共 5 条
[1]   Current and future antifungal therapy: new targets for antifungal agents [J].
Andriole, VT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) :151-162
[2]   Voriconazole: A new triazole antifungal agent [J].
Johnson, LB ;
Kauffman, CA .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :630-637
[3]   In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates [J].
MartinezSuarez, JV ;
RodriguezTudela, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1277-1279
[4]  
Sable C A, 2002, Transpl Infect Dis, V4, P25, DOI 10.1034/j.1399-3062.2002.01004.x
[5]   Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis [J].
Wingard, JR ;
Kubilis, P ;
Lee, L ;
Yee, G ;
White, M ;
Walshe, L ;
Bowden, R ;
Anaissie, E ;
Hiemenz, J ;
Lister, J .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) :1402-1407
1